• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

21-羟基-6,19-环氧孕酮半琥珀酸酯:糖皮质激素受体的组织特异性调节剂。

Hemisuccinate of 21-hydroxy-6,19-epoxyprogesterone: a tissue-specific modulator of the glucocorticoid receptor.

作者信息

Alvarez Lautaro D, Martí Marcelo A, Veleiro Adriana S, Misico Rosana I, Estrin Darío A, Pecci Adalí, Burton Gerardo

机构信息

Departamento de Química Orgánica and UMYMFOR-CONICET, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad Universitaria, Pabellón 2, C1428EGA Buenos Aires, Argentina.

出版信息

ChemMedChem. 2008 Dec;3(12):1869-77. doi: 10.1002/cmdc.200800256.

DOI:10.1002/cmdc.200800256
PMID:18985652
Abstract

The introduction of a hemisuccinate group at the 21-position of the passive antiglucocorticoid 21OH-6,19OP leads to a compound (21HS-6,19OP) with a notable activity profile toward the glucocorticoid receptor (GR). In contrast to the parent steroid, 21HS-6,19OP behaves as a pure agonist of GR activity in direct transactivation assays. However, the apoptotic effects of 21HS-6,19OP show that the effect depends on cell type: while 21HS-6,19OP is a pure agonist in L929 mouse fibroblasts, in thymocytes 21HS-6,19OP had significant antiglucocorticoid activity. This tissue-specific activity makes 21HS-6,19OP a novel selective GR modulator. To investigate the molecular basis of action of 21HS-6,19OP, we carried out molecular dynamics simulations (6 ns) of the GR ligand binding domain (LBD) complexed with 21HS-6,19OP. Our results indicate that the hemisuccinate moiety may play a key role in stabilizing the active conformation of the receptor dimerization interface, reverting the changes observed with the antagonist 21OH-6,19OP. Other changes in regions of the GR related to cofactor recruitment (possibly tissue-specific), could explain this particular activity profile.

摘要

在被动抗糖皮质激素21OH - 6,19OP的21位引入半琥珀酸基团,可得到一种对糖皮质激素受体(GR)具有显著活性特征的化合物(21HS - 6,19OP)。与母体类固醇不同,在直接反式激活试验中,21HS - 6,19OP表现为GR活性的纯激动剂。然而,21HS - 6,19OP的凋亡作用表明,其作用取决于细胞类型:在L929小鼠成纤维细胞中,21HS - 6,19OP是一种纯激动剂,而在胸腺细胞中,21HS - 6,19OP具有显著的抗糖皮质激素活性。这种组织特异性活性使21HS - 6,19OP成为一种新型的选择性GR调节剂。为了研究21HS - 6,19OP的作用分子基础,我们对与21HS - 6,19OP复合的GR配体结合域(LBD)进行了分子动力学模拟(6纳秒)。我们的结果表明,半琥珀酸部分可能在稳定受体二聚化界面的活性构象中起关键作用,逆转了拮抗剂21OH - 6,19OP所观察到的变化。GR中与辅因子募集相关区域的其他变化(可能具有组织特异性),可以解释这种特殊的活性特征。

相似文献

1
Hemisuccinate of 21-hydroxy-6,19-epoxyprogesterone: a tissue-specific modulator of the glucocorticoid receptor.21-羟基-6,19-环氧孕酮半琥珀酸酯:糖皮质激素受体的组织特异性调节剂。
ChemMedChem. 2008 Dec;3(12):1869-77. doi: 10.1002/cmdc.200800256.
2
Exploring the molecular basis of action of the passive antiglucocorticoid 21-hydroxy-6,19-epoxyprogesterone.探索被动抗糖皮质激素21-羟基-6,19-环氧孕酮的作用分子基础。
J Med Chem. 2008 Mar 13;51(5):1352-60. doi: 10.1021/jm800007w. Epub 2008 Feb 20.
3
The rigid steroid 21-hydroxy-6,19-epoxyprogesterone (21OH-6,19OP) is a dissociated glucocorticoid receptor modulator potentially useful as a novel coadjuvant in breast cancer chemotherapy.刚性甾体 21-羟基-6,19-环氧黄体酮(21OH-6,19OP)是一种分离的糖皮质激素受体调节剂,可能作为乳腺癌化疗的新型辅助药物具有应用价值。
Biochem Pharmacol. 2014 Jun 15;89(4):526-35. doi: 10.1016/j.bcp.2014.04.006. Epub 2014 Apr 13.
4
21-Hydroxy-6,19-epoxyprogesterone: A Promising Therapeutic Agent and a Molecular Tool for Deciphering Glucocorticoid Action.21-羟基-6,19-环氧孕酮:一种有前景的治疗药物及用于解读糖皮质激素作用的分子工具。
Mini Rev Med Chem. 2018 Feb 14;18(5):428-438. doi: 10.2174/1389557516666160118112313.
5
New lead compounds in the search for pure antiglucocorticoids and the dissociation of antiglucocorticoid effects.寻找纯抗糖皮质激素及抗糖皮质激素效应解离过程中的新型先导化合物。
J Steroid Biochem Mol Biol. 2009 Feb;113(3-5):155-62. doi: 10.1016/j.jsbmb.2008.12.018. Epub 2009 Jan 9.
6
The glucocorticoid agonist activities of mifepristone (RU486) and progesterone are dependent on glucocorticoid receptor levels but not on EC50 values.米非司酮(RU486)和孕酮的糖皮质激素激动剂活性取决于糖皮质激素受体水平,而非半数有效浓度(EC50)值。
Steroids. 2007 Jun;72(6-7):600-8. doi: 10.1016/j.steroids.2007.03.012. Epub 2007 Apr 7.
7
Dehydroepiandrosterone and its 7-hydroxylated metabolites do not interfere with the transactivation and cellular trafficking of the glucocorticoid receptor.脱氢表雄酮及其7-羟基化代谢产物不会干扰糖皮质激素受体的反式激活和细胞转运。
J Steroid Biochem Mol Biol. 2004 Dec;92(5):469-76. doi: 10.1016/j.jsbmb.2004.10.014. Epub 2004 Dec 19.
8
Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction.通过糖皮质激素受体进行的配体选择性反式激活和反式抑制:辅因子相互作用的作用
Mol Cell Endocrinol. 2009 Feb 27;299(2):219-31. doi: 10.1016/j.mce.2008.10.008. Epub 2008 Oct 19.
9
Modelling the glucocorticoid receptor and producing therapeutic agents with anti-inflammatory effects but reduced side-effects.对糖皮质激素受体进行建模,并研发出具有抗炎作用但副作用较小的治疗药物。
Exp Physiol. 2007 Mar;92(2):299-309. doi: 10.1113/expphysiol.2006.036194. Epub 2006 Nov 30.
10
Trifluoromethyl group as a pharmacophore: effect of replacing a CF3 group on binding and agonist activity of a glucocorticoid receptor ligand.
Bioorg Med Chem Lett. 2005 Nov 1;15(21):4761-9. doi: 10.1016/j.bmcl.2005.07.025.

引用本文的文献

1
The Role of Conformational Dynamics and Allostery in the Control of Distinct Efficacies of Agonists to the Glucocorticoid Receptor.构象动力学和变构作用在控制激动剂对糖皮质激素受体不同效能中的作用
Front Mol Biosci. 2022 Jul 7;9:933676. doi: 10.3389/fmolb.2022.933676. eCollection 2022.
2
Dual targeting of cytokine storm and viral replication in COVID-19 by plant-derived steroidal pregnanes: An in silico perspective.植物源性甾体孕烷通过靶向细胞因子风暴和 COVID-19 中的病毒复制:一种计算机视角。
Comput Biol Med. 2021 Jul;134:104406. doi: 10.1016/j.compbiomed.2021.104406. Epub 2021 Apr 18.
3
GR Dimerization and the Impact of GR Dimerization on GR Protein Stability and Half-Life.
GR 二聚化及其对 GR 蛋白稳定性和半衰期的影响。
Front Immunol. 2019 Jul 17;10:1693. doi: 10.3389/fimmu.2019.01693. eCollection 2019.
4
Exploring the binding properties of agonists interacting with glucocorticoid receptor: an in silico approach.探索激动剂与糖皮质激素受体相互作用的结合特性:一种计算机模拟方法。
J Mol Model. 2018 Nov 20;24(12):342. doi: 10.1007/s00894-018-3879-1.
5
Selective glucocorticoid receptor-activating adjuvant therapy in cancer treatments.癌症治疗中的选择性糖皮质激素受体激活辅助疗法。
Oncoscience. 2016 Jul 27;3(7-8):188-202. doi: 10.18632/oncoscience.315. eCollection 2016.
6
Expansion of CD11b(+)Ly6G (+)Ly6C (int) cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functions.孕激素(醋酸甲羟孕酮)促进荷瘤小鼠 CD11b(+)Ly6G (+)Ly6C (int) 细胞扩增,抑制 NK 细胞效应功能。
Cancer Immunol Immunother. 2013 Dec;62(12):1781-95. doi: 10.1007/s00262-013-1483-x. Epub 2013 Oct 11.
7
Allosteric analysis of glucocorticoid receptor-DNA interface induced by cyclic Py-Im polyamide: a molecular dynamics simulation study.环吡咯并咪唑聚酰胺诱导的糖皮质激素受体-DNA 界面的变构分析:分子动力学模拟研究。
PLoS One. 2012;7(4):e35159. doi: 10.1371/journal.pone.0035159. Epub 2012 Apr 19.
8
Insights on glucocorticoid receptor activity modulation through the binding of rigid steroids.通过刚性甾体与糖皮质激素受体的结合来深入了解糖皮质激素受体活性的调节。
PLoS One. 2010 Oct 11;5(10):e13279. doi: 10.1371/journal.pone.0013279.